| Trial Identifier: | D5670C00007 |
| Sponsor: | MedImmune, LLC |
| NCTID:: | NCT03444584 |
| Start Date: | May 2018 |
| Primary Completion Date: | December 2018 |
| Study Completion Date: | December 2018 |
| Condition: | Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| Hungarian Translation | |
| German Translation |
| Country | Location |
|---|---|
| Germany | Magdeburg, Germany, 39120 |
| Germany | Mannheim, Germany, 68167 |
| Germany | Mönchengladbach, Germany, 41061 |
| Germany | München, Germany, 81241 |
| Hungary | Balatonfüred, Hungary, 8230 |
| Hungary | Debrecen, Hungary, 4031 |
| Hungary | Miskolc, Hungary, 3529 |
| Hungary | Szeged, Hungary, 6720 |
| United Kingdom | Dundee, United Kingdom, DD1 9SY |
| United Kingdom | Liverpool, United Kingdom, L7 8XP |
| United Kingdom | Manchester, United Kingdom, M13 9NQ |
| United Kingdom | Manchester, United Kingdom, M13 9WL |
| United Kingdom | Rotherham, United Kingdom, S65 1DA |
| United Kingdom | Swansea, United Kingdom, SA2 8PP |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company